Meiyan Wang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Atopic Dermatitis

Top Venues

Nature communications

Science advances

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Fengjuan Xie, Shasha Tang, Ye Zhang, Yinbing Zhao, Yingying Lin, Yining Yao, Meiyan Wang, Zhengying Gu, Jingjing Wan
Designing Peptide-Based Nanoinhibitors of Programmed Cell Death Ligand 1 (PD-L1) for Enhanced Chemo-immunotherapy. ACS nano 18 (2) (2024)
Xin Wu, Yuanhuan Yu, Meiyan Wang, Di Dai, Jianli Yin, Wenjing Liu, Deqiang Kong, Shasha Tang, Meiyao Meng, Tian Gao, Yuanjin Zhang, Yang Zhou, Ningzi Guan, Shangang Zhao, Haifeng Ye
AAV-delivered muscone-induced transgene system for treating chronic diseases in mice via inhalation. Nature communications 15 (1) (2024)
Yuanhuan Yu, Xin Wu, Meiyan Wang, Wenjing Liu, Li Zhang, Ying Zhang, Zhilin Hu, Xuantong Zhou, Wenzheng Jiang, Qiang Zou, Fengfeng Cai, Haifeng Ye
Author Correction: Optogenetic-controlled immunotherapeutic designer cells for post-surgical cancer immunotherapy. Nature communications 15 (1) (2024)
Fengjuan Xie, Shasha Tang, Ye Zhang, Yinbing Zhao, Yingying Lin, Yining Yao, Meiyan Wang, Zhengying Gu, Jingjing Wan
Designing Peptide-Based Nanoinhibitors of Programmed Cell Death Ligand 1 (PD-L1) for Enhanced Chemo-immunotherapy. ACS nano (2024)
Fengjuan Xie, Shasha Tang, Ye Zhang, Yinbing Zhao, Yingying Lin, Yining Yao, Meiyan Wang, Zhengying Gu, Jingjing Wan
Designing Peptide-Based Nanoinhibitors of Programmed Cell Death Ligand 1 (PD-L1) for Enhanced Chemo-immunotherapy. ACS nano 18 (2) (2024)
Xin Wu, Yuanhuan Yu, Meiyan Wang, Di Dai, Jianli Yin, Wenjing Liu, Deqiang Kong, Shasha Tang, Meiyao Meng, Tian Gao, Yuanjin Zhang, Yang Zhou, Ningzi Guan, Shangang Zhao, Haifeng Ye
AAV-delivered muscone-induced transgene system for treating chronic diseases in mice via inhalation. Nature communications 15 (1) (2024)
Yuanhuan Yu, Xin Wu, Meiyan Wang, Wenjing Liu, Li Zhang, Ying Zhang, Zhilin Hu, Xuantong Zhou, Wenzheng Jiang, Qiang Zou, Fengfeng Cai, Haifeng Ye
Author Correction: Optogenetic-controlled immunotherapeutic designer cells for post-surgical cancer immunotherapy. Nature communications 15 (1) (2024)
Xin Wu, Yuanhuan Yu, Meiyan Wang, Di Dai, Jianli Yin, Wenjing Liu, Deqiang Kong, Shasha Tang, Meiyao Meng, Tian Gao, Yuanjin Zhang, Yang Zhou, Ningzi Guan, Shangang Zhao, Haifeng Ye
AAV-delivered muscone-induced transgene system for treating chronic diseases in mice via inhalation. Nature communications 15 (1) (2024)
Changping Deng, Shihui Li, Yuping Liu, Wen Bao, Chengnan Xu, Wenyun Zheng, Meiyan Wang, Xingyuan Ma
Split-Cas9-based targeted gene editing and nanobody-mediated proteolysis-targeting chimeras optogenetically coordinated regulation of Survivin to control the fate of cancer cells. Clinical and translational medicine 13 (8) (2023)
Yuanhuan Yu, Xin Wu, Meiyan Wang, Wenjing Liu, Li Zhang, Ying Zhang, Zhilin Hu, Xuantong Zhou, Wenzheng Jiang, Qiang Zou, Fengfeng Cai, Haifeng Ye
Optogenetic-controlled immunotherapeutic designer cells for post-surgical cancer immunotherapy. Nature communications 13 (1) (2022)
Xinyi Wang, Kaili Dong, Deqiang Kong, Yang Zhou, Jianli Yin, Fengfeng Cai, Meiyan Wang, Haifeng Ye
A far-red light-inducible CRISPR-Cas12a platform for remote-controlled genome editing and gene activation. Science advances 7 (50) (2021)